Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin Rieger

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Antiviral Therapy|August 23, 2012
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profilesGeorg Behrens, Renato Maserati, Armin Rieger, et al.
Atherosclerosis|October 7, 2005
Age and sex modulate metabolic and cardiovascular risk markers of patients after 1 year of highly active antiretroviral therapy (HAART)Judith Maria Leitner, Heidemarie Pernerstorfer-Schoen, Alina Weiss, et al.
Plos Pathogens|April 5, 2013
TIM-3 does not act as a receptor for galectin-9Judith Leitner, Armin Rieger, Winfried F Pickl, et al.
AJNR. American Journal of Neuroradiology|October 13, 2005
Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patientsMajda M Thurnher, Mauricio Castillo, Alfred Stadler, et al.
Journal of Clinical Microbiology|January 7, 2005
Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidityElisabeth Puchhammer-Stöckl, Brigitte Schmied, Armin Rieger, et al.
Plos One|September 12, 2013
Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort levelNinon Taylor, Katharina Grabmeier-Pfistershammer, Alexander Egle, et al.
International Journal of STD & AIDS|May 19, 2005
Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wastingStephan Klauke, Harald Fischer, Armin Rieger, et al.
Clinical Immunology (Orlando, Fla.)|September 9, 2017
Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockadeKatharina Grabmeier-Pfistershammer, Carmen Stecher, Markus Zettl, et al.
Medicine|July 19, 2016
Bacillary angiomatosis presenting with facial tumor and multiple abscesses: A case reportMateusz Markowicz, Stephanie Käser, Andreas Müller, et al.
Wiener Klinische Wochenschrift|October 26, 2019
Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in AustriaKatharina Grabmeier-Pfistershammer, Kay Holleis, Sandra Rosskopf, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Antiviral Therapy|August 23, 2012
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profilesGeorg Behrens, Renato Maserati, Armin Rieger, et al.
Atherosclerosis|October 7, 2005
Age and sex modulate metabolic and cardiovascular risk markers of patients after 1 year of highly active antiretroviral therapy (HAART)Judith Maria Leitner, Heidemarie Pernerstorfer-Schoen, Alina Weiss, et al.
Plos Pathogens|April 5, 2013
TIM-3 does not act as a receptor for galectin-9Judith Leitner, Armin Rieger, Winfried F Pickl, et al.
AJNR. American Journal of Neuroradiology|October 13, 2005
Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patientsMajda M Thurnher, Mauricio Castillo, Alfred Stadler, et al.
Journal of Clinical Microbiology|January 7, 2005
Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidityElisabeth Puchhammer-Stöckl, Brigitte Schmied, Armin Rieger, et al.
Plos One|September 12, 2013
Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort levelNinon Taylor, Katharina Grabmeier-Pfistershammer, Alexander Egle, et al.
International Journal of STD & AIDS|May 19, 2005
Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wastingStephan Klauke, Harald Fischer, Armin Rieger, et al.
Clinical Immunology (Orlando, Fla.)|September 9, 2017
Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockadeKatharina Grabmeier-Pfistershammer, Carmen Stecher, Markus Zettl, et al.
Medicine|July 19, 2016
Bacillary angiomatosis presenting with facial tumor and multiple abscesses: A case reportMateusz Markowicz, Stephanie Käser, Andreas Müller, et al.
Wiener Klinische Wochenschrift|October 26, 2019
Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in AustriaKatharina Grabmeier-Pfistershammer, Kay Holleis, Sandra Rosskopf, et al.
Pageof 6